Topics

Bristol Myers Squibb to Announce Results for First Quarter 2020 on May 7, 2020

06:58 EDT 26 Mar 2020 | Businesswire
Bristol-Myers Squibb Company

Bristol-Myers Squibb Company (NYSE: BMY) will announce results for the first quarter of 2020 on Thursday, May 7, 2020. During a conference call at 8:30 a.m. ET on May 7, 2020, company executives will review financial information and address inquiries from analysts.

Investors and the general public are invited to listen to a live webcast of the call at bms.com/investors or by dialing in the U.S. toll free 888-256-1007 or international 1-786-789-4797, confirmation code: 3261903. Materials related to the call will be available at the same website prior to the conference call. A replay of the call will be available beginning at 12 p.m. ET on May 7 through 12 p.m. ET on May 21, 2020. The replay will also be available through bms.com/investors or by dialing in the U.S. toll free 888-203-1112 or international 1-719-457-0820, confirmation code: 3261903.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

Bristol Myers Squibb
Media:
media@bms.com
609-252-3345

Investors:
Tim Power, 609-252-7509, timothy.power@bms.com
Nina Goworek, 908-673-9711, ngoworek@bms.com

NEXT ARTICLE

More From BioPortfolio on "Bristol Myers Squibb to Announce Results for First Quarter 2020 on May 7, 2020"

Quick Search

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...